NCT06676527 2025-12-05
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Recruiting
Jinling Hospital, China
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz
The Netherlands Cancer Institute